‌

US Patent 10662252 Disease therapy by inducing immune response to Trop-2 expressing cells

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

106622520

Date of Patent

May 26, 2020

Patent Application Number

158432520

Date Filed

December 15, 2017

Patent Citations Received

‌

US Patent 12006366 Methods and compositions for preventing type 1 diabetes

‌

US Patent 11547761 Antibody adjuvant conjugates

‌

US Patent 11400164 Immunoconjugates targeting HER2

‌

US Patent 11434291 Methods and compositions for preventing type 1 diabetes

Patent Primary Examiner

‌

Karen A. Canella

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10662252 Disease therapy by inducing immune response to Trop-2 expressing cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API